Novartis is proud to share that CEO Vas Narasimhan, M.D., has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health.

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Novartis is committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Schlaganfall-Lotsenprojekt in der Hauptstadtregion Berlin/Brandenburg gestartet. Es handelt sich um ein gemeinsames Kooperationsprojekt von der Stiftung Deutsche Schlaganfall-Hilfe, dem Jüdischen ...

FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

Das Umsatzwachstum beruhte auf der weiterhin starken Performance von Entresto (+22% kWk), Kisqali (+56% kWk), Kesimpta (+43% kWk), Cosentyx (+18% kWk), Leqvio (+72% kWk) und Scemblix (+76% kWk) Die ...